Medicine rrr.pdf

NEPHROLOGY

BIG QUESTION 1: What are the different types of Dyselectrolytemias?

  • Definition: Dyselectrolytemias refer to imbalances in sodium, potassium, and magnesium levels in the body.

1: Hyponatremia

  • Types: Can be classified as hypovolemic or euvolemic.

  • Treatment:

    • Hypovolemic: Administer fluids or restrict fluids depending on the context.

    • Euvolemic: Restrict fluids.

2: Hypernatremia

  • Causes: Commonly leads from dehydration.

  • Correction: Must be done slowly using hypotonic fluids.

3: Hypokalemia

  • Clinical Manifestations: ECG changes, including ST segment depression and U waves.

  • Treatment: Replenish potassium levels.

4: Hyperkalemia

  • Implications: Can cause life-threatening cardiac complications requiring urgent correction.

5: Magnesium Imbalances

  • Similar to hyperkalemia and require prompt correction to avoid cardiac issues.

DETAILED QUESTIONS

Q1.1: Formula for Calculating Total Sodium Deficit

  • Female: Total Sodium Deficit = Weight × 0.5 × (Desired Na - Actual Na)

  • Male: Total Sodium Deficit = Weight × 0.6 × (Desired Na - Actual Na)

Q1.2: Key Features of Hypovolemic Hyponatremia

  • Total Body Sodium (TBS): Decreased

  • Total Body Water (TBW): Decreased

  • Causes:

    • Diarrhea

    • Vomiting

    • Cerebral salt wasting syndrome

    • Addison's Disease

  • Treatment: Oral Rehydration Solution (ORS) and Intravenous Fluids (IVF)

Q1.3: Key Features of Euvolemic Hyponatremia

  • Total Body Water (TBW): Increased

  • Total Body Sodium (TBS): Normal

  • Causes:

    • SIADH: Related conditions include cerebral toxoplasmosis and oat cell lung cancer.

    • Non-judicious use of IVF post-surgery.

    • Endurance sports-related depletion.

    • Hypothyroidism (thyroid hormones affect ADH regulation)

  • Treatment: Fluid restriction and Vaptans (a V2 receptor blocker)

Q1.4: Key Features of Hypervolemic Hyponatremia

  • Total Body Water (TBW): Increased (water>>salt)

  • Total Body Sodium (TBS): Increased

  • Causes:

    • Congestive Heart Failure (CHF)

    • Cirrhosis

    • Chronic Kidney Disease (CKD)

  • Treatment: Diuretics

Q1.5: Key Features of Hyponatremia

  • Dangerous Hyponatremia Level: Any Na < 125 mEq/L

  • Fast Correction Risks: Can lead to Osmotic Demyelination Syndrome, with stroke-like features.

  • Fluid of Choice for Correction:

    • Hypertonic Saline (3% saline) has Na = 514 mEq/L.

    • Normal Saline (0.9%) has Na = 154 mEq/L.

Q1.6: Key Features of Hypernatremia

  • Dangerous Hypernatremia Level: Na > 158 mEq/L.

  • Lead Causes:

    • Debility in old age leading to low water intake.

  • Causes (Mnemonic: MODEL):

    • M: Medication (e.g., Lithium causing nephrogenic diabetes insipidus).

    • O: Osmotic diuresis.

    • D: Diabetic Insipidus.

    • E: Excessive water loss.

    • L: Low water intake.

  • Note for Pediatrics: Improperly diluted ORS can cause doughy skin.

Q1.7: Clinical Features and Management of Hypernatremia

  • Clinical Features (Mnemonic: SALT):

    • S: Skin flushed.

    • A: Agitation.

    • L: Low-grade fever.

    • T: Increased thirst.

  • Investigation: Check urine osmolarity.

    • Low Urine Osmolality (< 250 mOsm): Indicative of diabetes insipidus.

    • High Urine Osmolality (> 400 mOsm): Possible lactulose osmotic diarrhea.

  • Formula for Correction (Symptomatic Patient):

    • TBW × (Actual Na - 140)/140

  • Correction Fluid: 5% Dextrose.

  • Management for Asymptomatic Hypernatremia: Encourage liberal water intake.

Q1.8: Key Features of Hypokalemia

  • Clinical Features:

    • Cramps

    • Ileus

    • Flaccid paralysis (prolonged weakness despite correction indicates hypomagnesemia).

  • Cause of Death: Diaphragmatic paralysis.

  • CVS Arrhythmia risk: Torsades de Pointes triggered by both hypokalemia and hypomagnesemia.

  • Trans Tubular Potassium Gradient: If > 4, indicates renal wasting caused by Gitelman or Bartter syndrome.

Q1.9: Pseudo-P-Pulmonale

  • Definition: Condition where you see tall P waves (>2.5mm), but without pulmonary artery hypertension.

  • ECG changes with hypokalemia: Notable ST↓, T-wave inversion, QT interval prolongation, and increased U waves.

Q1.10: Correction Rule for Hypokalemia

  • For K+ 3.0-3.5 mEq/L: Administer orally.

  • For K+ < 3.0 mEq/L: Administer intravenously.

  • Conversion: 1 ml KCl = 2 mEq; 1 ampule = 10 ml KCl contains 20 mEq.

  • Potassium's Effect: 20 mEq can raise blood potassium by 0.25 mEq/L.

Q1.11: ECG Findings of Hyperkalemia

  • Notable Features:

    • Tall, tented T-waves linked to potential cardiac issues.

    • ST segment elevation.

Q1.12: Treatment of Hyperkalemia

  • Mnemonic: CABG-D2

    • C: Calcium gluconate to counteract potassium effects on the heart.

    • A: Albuterol nebulization.

    • B: Bicarbonate (used only if metabolic acidosis is present).

    • G: Glucose + Insulin (facilitates potassium entry into cells; rapid drop of 0.5-1 mEq/hr with insulin drip).

    • Diuretics: Loop diuretics promote urinary potassium loss.

    • Most Effective Method: Dialysis for acute cases.

  • For Chronic Hyperkalemia: Use Patiromer and Sodium Polystyrene Sulfonate to bind K+.

Q1.13: Causes of Hypomagnesemia

  • Common Presentations:

    • Chronic diarrhea

    • Alcoholism

    • Use of Thiazides (which block TRPM6 receptor for magnesium reabsorption).

  • Conditions Leading to Magnesium Wasting: Gitelman syndrome.

Q1.14: Side Effects of Hypomagnesemia

  • Clinical Features:

    • Muscle cramps

    • Hypertension (as hypomagnesemia increases intracellular calcium)

    • Torsades de Pointes risk

    • Increased neuromuscular excitability (tremors, nystagmus, and athetosis)

Q1.15: Treatment of Hypomagnesemia

  • Administration:

    • Magnesium sulfate: Dependent on the deficit, can be given parenterally, intramuscularly, or intravenously.

    • Oral preparation: Magnesium oxide.

Q1.16: Key Features of Hypermagnesemia

  • Normal Values: 1.3-2.1 mEq/L.

  • Death Risk: Occurs if levels exceed 10 mEq/L, which can lead to asystole.

  • Causes:

    • Chronic Kidney Disease (CKD)

    • Eclampsia (overdose of MgSO4)

    • Antacid and laxative abuse.

  • Clinical Features:

    • Shock unresponsive to IV fluids and vasopressors.

    • Diminished Deep Tendon Reflexes (DTR).

    • Reduced urine output and respiratory rate.

Q1.17: Treatment of Hypermagnesemia

  • Management Approaches:

    • Vigorous Hydration: administration of normal saline.

    • Drug of Choice (DOC): Calcium gluconate, counteracts high magnesium levels.

    • Other Options: Hemodialysis may be employed in severe cases of hypermagnesemia.

Q1.18: Causes of Death and Treatment in Different Dyselectrolytemias

Cause of Death

Treatment

Sodium <125 mEq

3% saline

Sodium 158 mEq

Seizure

Potassium >8.0 mEq

KCL + IVF

Potassium <2.5 mEq

Calcium gluconate

Calcium 13 mg%

Ibandronate

Calcium <7 mg%

Calcium gluconate

Magnesium >10 mEq

Asystole

Magnesium <1.0 mEq

V. Arrhythmia

Q1.19: Difference Between Urinary Anion Gap and Anion Gap

  • Anion Gap Calculation:

    • Formula: (Na⁺) - (Cl⁻ + HCO₃⁻)

    • Normal Value: 12 mEq.

  • Urinary Anion Gap Calculation:

    • Formula: (Na⁺ + K⁺) - (Cl⁻)

  • Significance:

    • Normal Range: 0 (urinary conditions can influence different outcomes)

    • Negative Gap: Negative urinary anion gap implies diarrhea.

    • Positive Gap: Positive urinary anion gap suggests Renal Tubular Acidosis (RTA), characterized by hindered H⁺ excretion.

Q1.20: Key Features of Lactic Acidosis

  • Normal Levels: 2-4 mmol/L.

  • Types of Lactic Acidosis:

    • Type A: Result from hypoperfusion/shock.

    • Type B: Related to other conditions like:

    • Ketoacidosis (e.g., Alcohol, starvation).

    • Uremia ( Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD)).

    • Drug-induced (e.g., Metformin use in patients with eGFR < 30ml/min).

  • Toxins:

    • Methyl Alcohol (treated with Fomepizole).

    • Ethylene Glycol (treated with Fomepizole).

    • Other contributors: Liver disease, malignancy, and Total Parenteral Nutrition (TPN).

BIG QUESTION 2: Key Features, Causes, Diagnosis, and Treatment of Nephrotic Syndrome

  • Broad Definition: Nephrotic syndrome features significant proteinuria, hypoalbuminemia, edema, hyperlipidemia, lipiduria, and a state of hypercoagulability.

  • Primary Causes: Include FSGS, membranous nephropathy, minimal change disease, and the Finnish type.

  • Secondary Causes: Include diabetes, amyloidosis, and lupus.

  • Diagnosis Approach: Utilize urine protein quantification, microscopy, complement levels, and kidney biopsy.

  • Treatment Options: Steroid-responsive cases are managed with corticosteroids; resistant forms may require cyclosporine or tacrolimus, and cyclophosphamide or levamisole for side effects management. Diuretics manage edema, and timely treatment reduces complications.

Q2.1: Key Features of Nephrotic Syndrome

  • Massive Proteinuria: > 3.5 g of protein in urine within a 24-hour period. Spot sample demonstrating > 2 g protein/gram of urinary creatinine confirms diagnosis.

  • Hypoalbuminemia: Results in lowered oncotic pressure leading to edema.

  • Edema: Commonly starts in the periorbital region and migrates to the genital area and feet in progressive stages. Notably, girls can present with vulvar edema due to minimal change disease.

  • Hyperlipidemia: Associated with accelerated atherosclerosis seen in conditions like diabetes mellitus, hypothyroidism, metabolic syndrome, systemic lupus erythematosus (SLE), and rheumatoid arthritis.

  • Lipiduria: Characterized by oval fat bodies; similar presentations can occur in fat embolism syndrome and chyluria.

  • Hypercoagulable State: Results from loss of ceruloplasmin, ferritin, protein C, S, and antithrombin III, leading to elevated fibrinogen levels.

Q2.2: Difference Between Primary and Secondary Nephrotic Syndrome

  • Primary Nephrotic Syndrome Causes: Include Focal